I agree that this site is using cookies. You can find further informations here.
X
Gaube, Géraldine
47  results:
Search for persons X
?
1

Case Report: Cerebral Nocardiosis Caused by Nocardia cyriac..:

Courbin, Virginie ; Riller, Quentin ; Amegnizin, Jean-Louis...
Frontiers in Immunology.  13 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
2

Impact of Casirivimab-Imdevimab on Severe Acute Respiratory..:

Vellas, Camille ; Del Bello, Arnaud ; Gaube, Geraldine...
Open Forum Infectious Diseases.  9 (2022)  4 - p. , 2022
Link: https://doi.org/10.1093/..
 
?
3

Outcome of very high-risk patients treated by Sotrovimab fo..:

Martin-Blondel, Guillaume ; Marcelin, Anne-Genevieve ; Soulié, Cathia...
Journal of Infection.  84 (2022)  6 - p. e101-e104 , 2022
Link: https://doi.org/10.1016/..
 
?
4

Sotrovimab to prevent severe COVID-19 in high-risk patients..:

Martin-Blondel, Guillaume ; Marcelin, Anne-Genevieve ; Soulié, Cathia...
Journal of Infection.  85 (2022)  4 - p. e104-e108 , 2022
Link: https://doi.org/10.1016/..
 
?
5

Temocillin versus carbapenems for urinary tract infection d..:

Delory, Tristan ; Gravier, Simon ; Le Pluart, Diane...
International Journal of Antimicrobial Agents.  58 (2021)  1 - p. 106361 , 2021
Link: https://doi.org/10.1016/..
 
?
6

Characterization of HIV-1 diversity in various compartments..:

Gaube, Géraldine ; Armero, Alix ; Salmona, Maud...
Scientific Reports.  10 (2020)  1 - p. , 2020
Link: https://doi.org/10.1038/..
 
?
7

Epidemiology, Risk Factors, and Outcomes of Opportunistic I..:

Attias, Philippe ; Melica, Giovanna ; Boutboul, David...
Journal of Clinical Medicine.  8 (2019)  5 - p. 594 , 2019
Link: https://doi.org/10.3390/..
 
?
8

Sotrovimab to Prevent Severe COVID-19 in High-Risk Patients..:

Martin-Blondel, Guillaume ; Marcelin, Anne-Geneviève ; Soulié, Cathia...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.jinf.2022.06.033.  , 2022
Link: https://hal.sorbonne-uni..
 
?
9

Time to negative PCR conversion amongst high-risk patients ..:

Martin-Blondel, Guillaume ; Marcelin, Anne-Geneviève ; Soulié, Cathia...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.cmi.2022.12.016.  , 2022
Link: https://hal.sorbonne-uni..
 
?
10

Time to negative PCR conversion amongst high-risk patients ..:

Martin-Blondel, Guillaume ; Marcelin, Anne-Geneviève ; Soulié, Cathia...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.cmi.2022.12.016.  , 2022
Link: https://hal.sorbonne-uni..
 
?
11

Time to negative PCR conversion amongst high-risk patients ..:

Martin-Blondel, Guillaume ; Marcelin, Anne-Geneviève ; Soulié, Cathia...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.cmi.2022.12.016.  , 2022
Link: https://hal.sorbonne-uni..
 
?
12

Time to negative PCR conversion amongst high-risk patients ..:

Martin-Blondel, Guillaume ; Marcelin, Anne-Geneviève ; Soulié, Cathia...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.cmi.2022.12.016.  , 2022
Link: https://hal.sorbonne-uni..
 
?
13

Outcome of very high-risk patients treated by Sotrovimab fo..:

Martin-Blondel, Guillaume ; Marcelin, Anne-Genevieve ; Soulié, Cathia...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.jinf.2022.04.010.  , 2022
Link: https://hal.sorbonne-uni..
 
?
14

Outcome of very high-risk patients treated by Sotrovimab fo..:

Martin-Blondel, Guillaume ; Marcelin, Anne-Genevieve ; Soulié, Cathia...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.jinf.2022.04.010.  , 2022
Link: https://hal.sorbonne-uni..
 
?
15

Outcome of very high-risk patients treated by Sotrovimab fo..:

Martin-Blondel, Guillaume ; Marcelin, Anne-Genevieve ; Soulié, Cathia...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.jinf.2022.04.010.  , 2022
Link: https://hal.sorbonne-uni..
 
1-15